Acquisition of a portfolio of products from MSD-All conditions precedent met ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number: 1985/0002935/06 Share code: APN ISIN: ZAE000066692 (“Aspen Holdings”) FURTHER ANNOUNCEMENT REGARDING THE ACQUISITION FROM MSD OF A PORTFOLIO OF PRODUCTS BY ASPEN - CONDITIONS PRECEDENT MET Shareholders are referred to the announcements released by Aspen Holdings on 27 June, 1 October and 31 October 2013 wherein it was confirmed, inter alia, that Aspen had reached an agreement on an option granted to Aspen Global Incorporated (“AGI”) to acquire a portfolio of 11 branded finished dose form molecules (“the Products”) from MSD, covering a diverse range of therapeutic areas and including products that use APIs manufactured by the API Business recently acquired from MSD. It was also confirmed that AGI had, subsequently, exercised the option to acquire the Products on 31 October 2013 and that, subject to the fulfilment of certain conditions precedent, the effective date of the Product transaction resulting from the exercise of the option would be 31 December 2013. Aspen is pleased to confirm that all the contractual conditions precedent in respect of the Product acquisition have been met and that the acquisition of the Products will complete today, 31 December 2013. Durban 31 December 2013 Underwriters The Standard Bank of South Africa Limited Bank of America, N.A. Mandated Lead Arrangers and Bookrunners The Standard Bank of South Africa Limited Banc of America Securities Limited Sponsor: Investec Bank Limited Date: 31/12/2013 11:01:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.